These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Nonalcoholic steatohepatitis: the therapeutic challenge of a global epidemic. Schattenberg JM; Schuppan D Curr Opin Lipidol; 2011 Dec; 22(6):479-88. PubMed ID: 22002020 [TBL] [Abstract][Full Text] [Related]
23. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A; J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218 [TBL] [Abstract][Full Text] [Related]
24. Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease. Abrams GA; Kunde SS; Lazenby AJ; Clements RH Hepatology; 2004 Aug; 40(2):475-83. PubMed ID: 15368453 [TBL] [Abstract][Full Text] [Related]
25. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease. Parekh S; Anania FA Gastroenterology; 2007 May; 132(6):2191-207. PubMed ID: 17498512 [TBL] [Abstract][Full Text] [Related]
37. Epidemiology of the metabolic syndrome, 2002. Meigs JB Am J Manag Care; 2002 Sep; 8(11 Suppl):S283-92; quiz S293-6. PubMed ID: 12240700 [TBL] [Abstract][Full Text] [Related]
38. Nonalcoholic steatohepatitis: what we know in the new millennium. Harrison SA; Kadakia S; Lang KA; Schenker S Am J Gastroenterol; 2002 Nov; 97(11):2714-24. PubMed ID: 12425538 [TBL] [Abstract][Full Text] [Related]
39. Nonalcoholic fatty liver disease: defining a common problem. Gasbarrini G; Vero V; Miele L; Forgione A; Hernandez AP; Greco AV; Gasbarrini A; Grieco A Eur Rev Med Pharmacol Sci; 2005; 9(5):253-9. PubMed ID: 16231586 [TBL] [Abstract][Full Text] [Related]
40. Nonalcoholic fatty liver disease: a challenge for pediatricians. Widhalm K; Ghods E Int J Obes (Lond); 2010 Oct; 34(10):1451-67. PubMed ID: 20838401 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]